Quarterly report · Q2
6823.TEDINET S100S7PT
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥23.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.8bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥868m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥605m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.3bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥605m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥35.6bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥34.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥33.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.0bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥27.6bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥26.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥25.6bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.7bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.6bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥245m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥275m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥577m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥289m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥102.25 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.67 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥146.33 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.24 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.99 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 77.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥31m |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥6.3bn |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥6.3bn |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥763m |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥901m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥12.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥12.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥26m |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥5.8bn |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥5.8bn |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥400m |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥678m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥10.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥10.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 488
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net inv cf | Prior1YTDDuration | -14964000 | JPY |
| Other net inv cf | CurrentYTDDuration | -10255000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -245343000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -1324867000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -282571000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -269244000 | JPY |
| Other net fin cf | Prior1YTDDuration | -6104000 | JPY |
| Other net fin cf | CurrentYTDDuration | -5778000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -288675000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -275023000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | -17863000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -78507000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 975903000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 356779000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 7181413000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 5206561000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 8157316000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 5563341000 | JPY |
| Finished goods | Prior1YearInstant | 2016588000 | JPY |
| Finished goods | CurrentQuarterInstant | 2256731000 | JPY |
| Work in process | Prior1YearInstant | 1341227000 | JPY |
| Work in process | CurrentQuarterInstant | 1554631000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 3075072000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 3337077000 | JPY |
| Salaries sga | Prior1YTDDuration | 1295512000 | JPY |
| Salaries sga | CurrentYTDDuration | 1515475000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 425209000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 489573000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 86570000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 88724000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -1118000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 248000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01842-000MedicalEquipmentReportableSegmentsMember | 5759508000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 1978624000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01842-000ParticleCountersReportableSegmentMember | 3060113000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 10798246000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 10798246000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01842-000MedicalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01842-000EnvironmentalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01842-000ParticleCountersReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01842-000MedicalEquipmentReportableSegmentsMember | 5759508000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 1978624000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01842-000ParticleCountersReportableSegmentMember | 3060113000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 10798246000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 10798246000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |